Open AccessAbstract 2854: The potential of hyperpolarized 13-C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents
Author(s) -
Ane B. Iversen,
Morten Busk,
Lotte Bonde Bertelsen,
Christoffer Laustsen,
Ole Lajord Munk,
Thomas Nielsen,
Thomas R. Wittenborn,
Johan Bussink,
Jasper Lok,
Hans StødkildeJørgensen,
Michael R. Horsman
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-2854
Subject(s) - combretastatin , magnetic resonance imaging , nuclear medicine , perfusion , medicine , in vivo , fluorodeoxyglucose , necrosis , in vivo magnetic resonance spectroscopy , chemistry , positron emission tomography , pathology , radiology , microtubule , microbiology and biotechnology , biology , tubulin